Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 27.0 | 9.0 | 14.3 | 3.0 | 26.3 | 1.0 | 0.7 | 1.0 | 3.0 | 6.0 |
| 50.0% |
| 0.7 |
| 1.3 |
| 50.0% |
| 1.0 |
| 2.0 |
| 50.0% |
| Last 5 | 5 | 21.6 | 7.2 | 9.8 | 2.4 | 19.4 | 0.8 | 0.4 | 0.8 | 2.6 | 4.8 | 54.2% | 0.4 | 1.4 | 28.6% | 0.8 | 1.4 | 57.1% |
| Last 10 | 10 | 17.1 | 5.2 | 7.2 | 1.9 | 14.3 | 0.7 | 0.4 | 0.7 | 1.4 | 3.1 | 45.2% | 0.6 | 1.3 | 46.2% | 0.6 | 0.9 | 66.7% |
| Last 20 | 20 | 18.5 | 5.3 | 7.7 | 2.0 | 14.9 | 0.7 | 0.6 | 0.9 | 1.5 | 3.4 | 44.1% | 0.6 | 1.8 | 33.3% | 0.5 | 0.8 | 66.7% |
| Season | 63 | 19.5 | 6.4 | 8.4 | 1.3 | 16.1 | 0.6 | 0.8 | 1.0 | 2.0 | 3.9 | 51.4% | 0.5 | 1.4 | 35.6% | 0.8 | 1.3 | 63.1% |
high offensive rebounding, high rim finishing off the ball, high contested shots per minute, low off-ball shooting
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 22.5 | 12 | 12 | 3 | 1 | 1 | 0 | 5 | 10 | 50.0% | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 26.0 |
| 2026-04-10 | PHI @ IND | W | 28.6 | 10 | 16 | 1 | 1 | 0 | 0 | 4 | 10 | 40.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 24.0 |
| 2026-04-09 | PHI @ HOU | L | 30.0 | 5 | 15 | 5 | 1 | 1 | 3 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 1 | 4 | 25.0% | 7.0 |
| 2026-04-06 | PHI @ SAS | L | 8.6 | 5 | 3 | 1 | 0 | 0 | 0 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 1 | 1 | 100.0% | -6.0 |
| 2026-04-04 | PHI vs. DET | L | 18.3 | 4 | 3 | 2 | 1 | 0 | 1 | 2 | 5 | 40.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -15.0 |
| 2026-04-03 | PHI vs. MIN | W | 9.1 | 4 | 6 | 0 | 1 | 1 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 11.0 |
| 2026-04-01 | PHI @ WAS | W | 23.8 | 6 | 9 | 4 | 2 | 0 | 0 | 2 | 5 | 40.0% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-03-28 | PHI @ CHA | W | 6.3 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2026-03-25 | PHI vs. CHI | W | 5.2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-03-23 | PHI vs. OKC | L | 18.5 | 6 | 4 | 2 | 0 | 0 | 1 | 2 | 3 | 66.7% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-03-21 | PHI @ UTA | W | 20.6 | 4 | 8 | 2 | 0 | 4 | 2 | 2 | 5 | 40.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-03-19 | PHI @ SAC | W | 24.0 | 13 | 11 | 4 | 0 | 3 | 1 | 5 | 11 | 45.5% | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 13.0 |
| 2026-03-17 | PHI @ DEN | L | 28.1 | 9 | 10 | 3 | 0 | 0 | 0 | 4 | 10 | 40.0% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | -18.0 |
| 2026-03-15 | PHI vs. POR | W | 34.7 | 6 | 17 | 4 | 2 | 0 | 3 | 3 | 9 | 33.3% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 14.0 |
| 2026-03-09 | PHI @ CLE | L | 15.4 | 4 | 7 | 2 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -5.0 |
| 2026-03-07 | PHI @ ATL | L | 18.9 | 2 | 7 | 1 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-03-04 | PHI vs. UTA | W | 13.2 | 2 | 3 | 1 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 1.0 |
| 2026-03-03 | PHI vs. SAS | L | 5.2 | 2 | 3 | 0 | 0 | 0 | 0 | 1 | 7 | 14.3% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | -14.0 |
| 2026-03-01 | PHI @ BOS | L | 32.1 | 10 | 12 | 4 | 4 | 0 | 2 | 3 | 5 | 60.0% | 2 | 4 | 50.0% | 2 | 3 | 66.7% | -9.0 |
| 2026-02-24 | PHI @ IND | W | 6.8 | 2 | 3 | 0 | 1 | 0 | 0 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-02-22 | PHI @ MIN | W | 21.6 | 6 | 9 | 2 | 1 | 0 | 1 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | 2.0 |
| 2026-02-21 | PHI @ NOP | L | 21.2 | 5 | 12 | 1 | 1 | 1 | 2 | 2 | 7 | 28.6% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | -16.0 |
| 2026-02-19 | PHI vs. ATL | L | 27.9 | 10 | 14 | 3 | 0 | 2 | 0 | 4 | 6 | 66.7% | 1 | 1 | 100.0% | 1 | 1 | 100.0% | -7.0 |
| 2026-02-11 | PHI vs. NYK | L | 10.6 | 2 | 4 | 0 | 1 | 0 | 2 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-02-09 | PHI @ POR | L | 26.7 | 11 | 7 | 5 | 0 | 2 | 1 | 5 | 8 | 62.5% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -15.0 |
| 2026-02-03 | PHI @ GSW | W | 29.0 | 12 | 12 | 1 | 1 | 1 | 4 | 5 | 11 | 45.5% | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 7.0 |
| 2026-01-29 | PHI vs. SAC | W | 3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-01-26 | PHI @ CHA | L | 19.3 | 4 | 7 | 1 | 1 | 2 | 3 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | -25.0 |
| 2026-01-20 | PHI vs. PHX | L | 21.8 | 8 | 15 | 1 | 0 | 1 | 2 | 4 | 10 | 40.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -2.0 |
| 2026-01-14 | PHI vs. CLE | L | 12.0 | 7 | 9 | 0 | 0 | 0 | 1 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 5 | 6 | 83.3% | -8.0 |
| 2026-01-11 | PHI @ TOR | L | 19.8 | 0 | 5 | 0 | 0 | 1 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -16.0 |
| 2026-01-09 | PHI @ ORL | W | 16.6 | 7 | 6 | 0 | 1 | 1 | 0 | 3 | 7 | 42.9% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | 8.0 |
| 2026-01-07 | PHI vs. WAS | W | 12.4 | 11 | 4 | 1 | 2 | 1 | 0 | 3 | 6 | 50.0% | 2 | 3 | 66.7% | 3 | 4 | 75.0% | 15.0 |
| 2026-01-01 | PHI @ DAL | W | 6.8 | 2 | 4 | 0 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2025-12-28 | PHI @ OKC | L | 17.6 | 4 | 4 | 0 | 0 | 0 | 4 | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -14.0 |
| 2025-12-26 | PHI @ CHI | L | 7.9 | 2 | 4 | 0 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2025-12-23 | PHI vs. BKN | L | 16.6 | 12 | 13 | 0 | 0 | 0 | 1 | 5 | 10 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -10.0 |
| 2025-12-20 | PHI vs. DAL | W | 23.2 | 6 | 12 | 3 | 0 | 0 | 0 | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 1 | 4 | 25.0% | -10.0 |
| 2025-12-19 | PHI @ NYK | W | 32.3 | 14 | 13 | 1 | 0 | 1 | 1 | 4 | 7 | 57.1% | 3 | 4 | 75.0% | 3 | 3 | 100.0% | 9.0 |
| 2025-12-14 | PHI @ ATL | L | 19.8 | 5 | 10 | 3 | 1 | 3 | 0 | 2 | 6 | 33.3% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 6.0 |
| 2025-12-12 | PHI vs. IND | W | 16.1 | 0 | 9 | 1 | 0 | 2 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2025-12-07 | PHI vs. LAL | L | 17.7 | 11 | 12 | 0 | 0 | 1 | 0 | 5 | 11 | 45.5% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | -15.0 |
| 2025-12-05 | PHI @ MIL | W | 23.4 | 5 | 6 | 2 | 2 | 0 | 2 | 2 | 4 | 50.0% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | 8.0 |
| 2025-12-04 | PHI vs. GSW | W | 16.6 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-12-02 | PHI vs. WAS | W | 17.2 | 12 | 10 | 3 | 1 | 1 | 2 | 5 | 8 | 62.5% | 1 | 2 | 50.0% | 1 | 1 | 100.0% | 9.0 |
| 2025-11-30 | PHI vs. ATL | L | 6.0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2025-11-28 | PHI @ BKN | W | 10.5 | 7 | 4 | 1 | 0 | 1 | 0 | 2 | 2 | 100.0% | 1 | 1 | 100.0% | 2 | 2 | 100.0% | 9.0 |
| 2025-11-25 | PHI vs. ORL | L | 22.3 | 3 | 12 | 0 | 0 | 2 | 2 | 1 | 6 | 16.7% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -33.0 |
| 2025-11-23 | PHI vs. MIA | L | 38.0 | 14 | 24 | 1 | 0 | 2 | 2 | 6 | 12 | 50.0% | 1 | 2 | 50.0% | 1 | 2 | 50.0% | -2.0 |
| 2025-11-20 | PHI @ MIL | W | 18.3 | 3 | 8 | 1 | 1 | 1 | 1 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | -1.0 |
| 2025-11-19 | PHI vs. TOR | L | 34.0 | 10 | 12 | 0 | 2 | 1 | 3 | 5 | 9 | 55.6% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-11-17 | PHI vs. LAC | W | 37.9 | 14 | 18 | 0 | 1 | 0 | 1 | 5 | 8 | 62.5% | 1 | 2 | 50.0% | 3 | 4 | 75.0% | 2.0 |
| 2025-11-14 | PHI @ DET | L | 35.7 | 12 | 11 | 2 | 1 | 0 | 3 | 5 | 6 | 83.3% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-11-11 | PHI vs. BOS | W | 33.3 | 14 | 13 | 0 | 0 | 1 | 0 | 6 | 11 | 54.5% | 0 | 2 | 0.0% | 2 | 3 | 66.7% | 10.0 |
| 2025-11-09 | PHI vs. DET | L | 34.6 | 17 | 12 | 2 | 1 | 1 | 0 | 6 | 9 | 66.7% | 2 | 4 | 50.0% | 3 | 4 | 75.0% | -11.0 |
| 2025-11-08 | PHI vs. TOR | W | 16.1 | 4 | 8 | 1 | 0 | 1 | 1 | 1 | 5 | 20.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 8.0 |
| 2025-11-05 | PHI @ CLE | L | 28.1 | 13 | 13 | 1 | 1 | 2 | 1 | 6 | 7 | 85.7% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-02 | PHI @ BKN | W | 23.3 | 5 | 8 | 0 | 1 | 1 | 1 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 1 | 2 | 50.0% | 20.0 |
| 2025-10-31 | PHI vs. BOS | L | 11.7 | 6 | 2 | 0 | 1 | 1 | 0 | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 3 | 4 | 75.0% | 7.0 |
| 2025-10-28 | PHI @ WAS | W | 11.5 | 6 | 10 | 0 | 0 | 1 | 0 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2025-10-27 | PHI vs. ORL | W | 23.4 | 4 | 6 | 1 | 1 | 2 | 0 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 0 | 2 | 0.0% | -9.0 |
| 2025-10-25 | PHI vs. CHA | W | 15.8 | 7 | 13 | 2 | 2 | 0 | 0 | 3 | 6 | 50.0% | 0 | 1 | 0.0% | 1 | 3 | 33.3% | 12.0 |
| 2025-10-22 | PHI @ BOS | W | 2.7 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 2.0 |